Palvella Therapeutics (PVLA) Shares Outstanding (Weighted Average) (2013 - 2026)
Palvella Therapeutics (PVLA) reported Shares Outstanding (Weighted Average) of $13.1 million for Q1 2026, up 18.81% year-over-year from $11.0 million in Q1 2025, and up 16.3% on a QoQ basis from $11.3 million in Q4 2025.
Palvella Therapeutics (PVLA) has 14 years of Shares Outstanding (Weighted Average) data on file, last reported at $13.1 million in Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 18.81% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.1 million (up 18.81% YoY) and the FY2025 annual result came in at $11.3 million, up 405.46% from the prior year.
- Shares Outstanding (Weighted Average) advanced to $13.1 million in Q1 2026 per PVLA's latest filing, from $11.3 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $74.4 million in Q3 2022 and bottomed at $100000.0 in Q3 2024.
- The 5-year median for Shares Outstanding (Weighted Average) is $11.0 million (2025), against an average of $21.5 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) tumbled 98.74%; it then surged 10943.76% in 2025.
- Tracing PVLA's Shares Outstanding (Weighted Average) over 5 years: stood at $74.2 million in 2022, then sank by 97.61% to $1.8 million in 2023, then climbed by 25.75% to $2.2 million in 2024, then surged by 405.46% to $11.3 million in 2025, then climbed by 16.3% to $13.1 million in 2026.
- Per Business Quant, the three latest PVLA Shares Outstanding (Weighted Average) figures stand at $13.1 million (Q1 2026), $11.3 million (Q4 2025), and $11.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | 13.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.09 Mn |
| Dec 31, 2025 | 11.25 Mn |
| Sep 30, 2025 | 11.04 Mn |
| Jun 30, 2025 | 11.05 Mn |
| Mar 31, 2025 | 11.01 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.24 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 931,000.00 |
| Dec 31, 2022 | 74.17 Mn |
| Sep 30, 2022 | 74.40 Mn |
| Jun 30, 2022 | 74.13 Mn |
| Mar 31, 2022 | 73.71 Mn |
| Dec 31, 2021 | 64.55 Mn |
| Sep 30, 2021 | 67.73 Mn |
| Jun 30, 2021 | 61.91 Mn |
| Mar 31, 2021 | 56.30 Mn |
| Dec 31, 2020 | 54.48 Mn |
| Sep 30, 2020 | 54.34 Mn |
| Jun 30, 2020 | 53.79 Mn |
| Mar 31, 2020 | 55.21 Mn |
| Dec 31, 2019 | 50.63 Mn |
| Sep 30, 2019 | 49.35 Mn |
| Jun 30, 2019 | 49.20 Mn |
| Mar 31, 2019 | 50.87 Mn |
| Dec 31, 2018 | 53.08 Mn |
| Sep 30, 2018 | 54.09 Mn |
| Jun 30, 2018 | 53.98 Mn |
| Mar 31, 2018 | 50.05 Mn |
| Dec 31, 2017 | 43.93 Mn |
| Sep 30, 2017 | 43.62 Mn |
| Jun 30, 2017 | 43.24 Mn |
| Mar 31, 2017 | 43.06 Mn |
| Dec 31, 2016 | 41.71 Mn |
| Sep 30, 2016 | 43.06 Mn |
| Jun 30, 2016 | 40.86 Mn |
| Mar 31, 2016 | 39.83 Mn |
| Dec 31, 2015 | 34.39 Mn |
| Sep 30, 2015 | 38.89 Mn |
| Jun 30, 2015 | 29.43 Mn |
| Mar 31, 2015 | 29.29 Mn |
| Dec 31, 2014 | 13.87 Mn |
| Sep 30, 2014 | 5.00 Mn |
| Jun 30, 2014 | 11.83 Mn |
| Mar 31, 2014 | 11.83 Mn |
| Dec 31, 2013 | 11.83 Mn |
| Sep 30, 2013 | 6.10 Mn |
| Jun 30, 2013 | 5.00 Mn |